Table 1.
Description of study sites in Southern Province, Zambia, 2016–2018
| Study site | Location | Type of area | Study period | Median (range) HIV+ women delivering per week | Eligible participants |
|---|---|---|---|---|---|
| Livingstone Central Hospital | Livingstone City | Urban |
Jun 2016 to May 2017 Jun 2017 to Apr 2018 |
8 (1, 15) |
All HIV+ women High-risk HIV+ womena |
| Maramba UHC | Livingstone City | Urban |
Jun 2016 to May 2017 Jun 2017 to Apr 2018 |
3 (0, 12) |
All HIV+ women High-risk HIV+ womena |
| Mahatma Gandhi UHC | Livingstone City | Urban | Apr 2017 to Apr 2018 | 3 (0, 9) | High-risk HIV+ womena |
| Libuyu UHC | Livingstone City | Urban | Apr 2017 to Apr 2018 | 1 (0, 5) | High-risk HIV+ womena |
| Choma General Hospital | Choma Town | Urban | Aug 2017 to Apr 2018 | 5 (2, 9) | High-risk HIV+ womena |
| Shampande UHC | Choma Town | Urban | Aug 2017 to Apr 2018 | 2 (0, 5) | High-risk HIV+ womena |
| Macha Hospital | Macha Area | Rural | Feb 2016 to Aug 2018 | 2 (0, 9) | All HIV+ women |
| Mapanza RHC | Macha Area | Rural | Feb 2016 to Aug 2018 | 0 (0, 4) | All HIV+ women |
| Moboola RHC | Macha Area | Rural | Feb 2016 to Aug 2018 | 0 (0, 3) | All HIV+ women |
| Mangunza RHC | Macha Area | Rural | Feb 2016 to Aug 2018 | 0 (0, 3) | All HIV+ women |
| Nalube RHC | Macha Area | Rural | Feb 2016 to Jul 2017 | 0 (0, 2) | All HIV+ women |
RHC Rural health center, UHC Urban health center
aHigh-risk defined as receiving no antiretroviral drugs throughout pregnancy or starting to receive antiretroviral drugs during pregnancy to prevent mother-to-child transmission